These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells. Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678 [TBL] [Abstract][Full Text] [Related]
4. Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice. Cui W; Li B; Bai Y; Miao X; Chen Q; Sun W; Tan Y; Luo P; Zhang C; Zheng S; Epstein PN; Miao L; Cai L Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E87-99. PubMed ID: 23132297 [TBL] [Abstract][Full Text] [Related]
5. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway. Qiao S; Liu R; Lv C; Miao Y; Yue M; Tao Y; Wei Z; Xia Y; Dai Y Free Radic Biol Med; 2019 Dec; 145():118-135. PubMed ID: 31494242 [TBL] [Abstract][Full Text] [Related]
6. SP600125 suppresses Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684 [TBL] [Abstract][Full Text] [Related]
7. Carnosic acid improves diabetic nephropathy by activating Nrf2/ARE and inhibition of NF-κB pathway. Xie Z; Zhong L; Wu Y; Wan X; Yang H; Xu X; Li P Phytomedicine; 2018 Aug; 47():161-173. PubMed ID: 30166101 [TBL] [Abstract][Full Text] [Related]
8. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease. Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532 [TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect. Yang Y; Chen G; Cheng X; Teng Z; Cai X; Yang J; Sun X; Lu W; Wang X; Yao Y; Hu C; Cao P Sci Rep; 2015 Jul; 5():12377. PubMed ID: 26205695 [TBL] [Abstract][Full Text] [Related]
11. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635 [TBL] [Abstract][Full Text] [Related]
12. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443 [TBL] [Abstract][Full Text] [Related]
13. Nrf2 ameliorates diabetic nephropathy progression by transcriptional repression of TGFβ1 through interactions with c-Jun and SP1. Gao P; Li L; Ji L; Wei Y; Li H; Shang G; Zhao Z; Chen Q; Jiang T; Zhang N Biochim Biophys Acta; 2014 Nov; 1839(11):1110-20. PubMed ID: 25046864 [TBL] [Abstract][Full Text] [Related]
14. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation. Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771 [TBL] [Abstract][Full Text] [Related]
15. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417 [TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023 [TBL] [Abstract][Full Text] [Related]